chrisvoncsefalvay/vaers-narrative-generation huggingface dataset:
Sex: U
Vaccine: COVID19
Symptoms: Drug screen positive
Clinical narrative: Tested positive for oxycodone after getting 2nd dose of the vaccine; Based on the current case data, this case has been classified as invalid. This spontaneous case was reported by a consumer and describes the occurrence of DRUG SCREEN POSITIVE (Tested positive for oxycodone after getting 2nd dose of the vaccine) in a patient of an unknown age and gender who received mRNA-1273 (Moderna COVID-19 Vaccine) for COVID-19 vaccination.     No Medical History information was reported.   On an unknown date, the patient received second dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. On an unknown date, received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) dosage was changed to 1 dosage form. On an unknown date, the patient experienced DRUG SCREEN POSITIVE (Tested positive for oxycodone after getting 2nd dose of the vaccine). At the time of the report, DRUG SCREEN POSITIVE (Tested positive for oxycodone after getting 2nd dose of the vaccine) outcome was unknown.            No concomitant product use was provided by the reporter. No treatment medication was provided.
Age: 57.0
Sex: M
Vaccine: COVID19
Symptoms: Myalgia
Clinical narrative: Soreness in right arm/soreness in the right arm lasted for a few days; This spontaneous case was reported by a consumer and describes the occurrence of MYALGIA (Soreness in right arm/soreness in the right arm lasted for a few days) in a 57-year-old male patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 054C21A) for COVID-19 vaccination.     No medical history was provided by the reporter.  Concomitant products included FLUOXETINE, LISINOPRIL, TRAZODONE and FENOFIBRATE for an unknown indication.   On 27-May-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. On 18-Jul-2021, received second dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) dosage was changed to 1 dosage form. On 27-May-2021, the patient experienced MYALGIA (Soreness in right arm/soreness in the right arm lasted for a few days). At the time of the report, MYALGIA (Soreness in right arm/soreness in the right arm lasted for a few days) outcome was unknown.        The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Unknown) was unknown.   For mRNA-1273 (Moderna COVID-19 Vaccine) (Unknown), the reporter did not provide any causality assessments.   No treatment details were reported.   This case was linked to MOD-2021-260608 (Patient Link).
Age: 57.0
Sex: M
Vaccine: COVID19
Symptoms: Dizziness, Fatigue, Headache, Inappropriate schedule of product administration, Myalgia
Clinical narrative: Soreness in right arm/body ache; Headache; Tired/Just feeling drained; Dizziness; Received 2nd dose past the 42 day mark; soreness in right arm; This spontaneous case was reported by a consumer and describes the occurrence of DIZZINESS (Dizziness), INAPPROPRIATE SCHEDULE OF PRODUCT ADMINISTRATION (Received 2nd dose past the 42 day mark), MYALGIA (Soreness in right arm/body ache), HEADACHE (Headache) and FATIGUE (Tired/Just feeling drained) in a 57-year-old male patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch nos. 054C21A and 054C21A) for COVID-19 vaccination. The occurrence of additional non-serious events is detailed below.     No medical history was provided by the reporter.  Concomitant products included FLUOXETINE, LISINOPRIL, TRAZODONE and FENOFIBRATE for an unknown indication.   On 27-May-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. On 18-Jul-2021, received second dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) dosage was changed to 1 dosage form. On 27-May-2021, the patient experienced INAPPROPRIATE SCHEDULE OF PRODUCT ADMINISTRATION (Received 2nd dose past the 42 day mark) and MYALGIA (soreness in right arm). On 18-Jul-2021, the patient experienced DIZZINESS (Dizziness), MYALGIA (Soreness in right arm/body ache), HEADACHE (Headache) and FATIGUE (Tired/Just feeling drained). On 18-Jul-2021, DIZZINESS (Dizziness) and INAPPROPRIATE SCHEDULE OF PRODUCT ADMINISTRATION (Received 2nd dose past the 42 day mark) had resolved. At the time of the report, MYALGIA (Soreness in right arm/body ache), HEADACHE (Headache), FATIGUE (Tired/Just feeling drained) and MYALGIA (soreness in right arm) outcome was unknown.        The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Unknown) was unknown.       No treatment information were reported.   This case was linked to MOD-2021-260575
Sex: F
Vaccine: COVID19
Symptoms: Heavy menstrual bleeding, Menstruation irregular
Clinical narrative: Period stopped on July 3, got 2nd dose July 10, and got a bonus period on the 11-th; Bleeding from uterus 3 days longer than normal; This spontaneous case was reported by a consumer and describes the occurrence of HEAVY MENSTRUAL BLEEDING (Bleeding from uterus 3 days longer than normal) and MENSTRUATION IRREGULAR (Period stopped on July 3, got 2nd dose July 10, and got a bonus period on the 11-th) in a female patient of an unknown age who received mRNA-1273 (Moderna COVID-19 Vaccine) for COVID-19 vaccination.     No Medical History information was reported.   On 10-Jul-2021, the patient received second dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) dosage was changed to 1 dosage form. On an unknown date, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. On 19-Jul-2021, the patient experienced HEAVY MENSTRUAL BLEEDING (Bleeding from uterus 3 days longer than normal). On an unknown date, the patient experienced MENSTRUATION IRREGULAR (Period stopped on July 3, got 2nd dose July 10, and got a bonus period on the 11-th). At the time of the report, HEAVY MENSTRUAL BLEEDING (Bleeding from uterus 3 days longer than normal) and MENSTRUATION IRREGULAR (Period stopped on July 3, got 2nd dose July 10, and got a bonus period on the 11-th) outcome was unknown.            No concomitant medications were provided.   No treatment medications were provided.
Sex: U
Vaccine: COVID19
Symptoms: Product dose omission issue
Clinical narrative: Missed 2nd dose; This spontaneous case was reported by a consumer and describes the occurrence of PRODUCT DOSE OMISSION ISSUE (Missed 2nd dose) in a patient of an unknown age and gender who received mRNA-1273 (Moderna COVID-19 Vaccine) for COVID-19 vaccination.     No Medical History information was reported.    On an unknown date, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On an unknown date, the patient experienced PRODUCT DOSE OMISSION ISSUE (Missed 2nd dose). At the time of the report, PRODUCT DOSE OMISSION ISSUE (Missed 2nd dose) outcome was unknown.        The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) was unknown.
Age: 72.0
Sex: M
Vaccine: COVID19
Symptoms: Chills, Fatigue, Hyperhidrosis, Influenza like illness, Myalgia
Clinical narrative: muscle aches; tiredness; chills that progressed to shaking; awoke in the middle of the night with profuse sweating; flu-like symptoms; cold; shaking; chills; fatigue; muscle aches; sweating; This spontaneous case was reported by a consumer and describes the occurrence of INFLUENZA LIKE ILLNESS (flu-like symptoms), NASOPHARYNGITIS (cold), TREMOR (shaking), CHILLS (chills) and FATIGUE (fatigue) in a 72-year-old male patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch nos. 032120A and 033M20A) for COVID-19 vaccination. The occurrence of additional non-serious events is detailed below.     No medical history was provided by the reporter.  Concomitant products included MULTI VITAMIN [ASCORBIC ACID;COLECALCIFEROL;NICOTINAMIDE;PANTHENOL;PYRIDOXINE HYDROCHLORIDE;RETINOL PALMITATE;RIBOFLAVIN;THIAMINE HYDROCHLORIDE;TOCOPHERYL ACETATE], FEXOFENADINE, LEVOTHYROXINE and ATORVASTATIN for an unknown indication.   On 29-Jan-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. On 26-Feb-2021, received second dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) dosage was changed to 1 dosage form. On 27-Feb-2021, the patient experienced INFLUENZA LIKE ILLNESS (flu-like symptoms), NASOPHARYNGITIS (cold), TREMOR (shaking), CHILLS (chills), FATIGUE (fatigue), the first episode of MYALGIA (muscle aches) and HYPERHIDROSIS (sweating). On 18-Jul-2021, the patient experienced the second episode of MYALGIA (muscle aches), FATIGUE (tiredness), TREMOR (chills that progressed to shaking) and HYPERHIDROSIS (awoke in the middle of the night with profuse sweating). The patient was treated with ASPIRIN [ACETYLSALICYLIC ACID] at a dose of 2 UNK. On 28-Feb-2021, INFLUENZA LIKE ILLNESS (flu-like symptoms), NASOPHARYNGITIS (cold), TREMOR (shaking), CHILLS (chills), FATIGUE (fatigue) and HYPERHIDROSIS (sweating) had resolved. On 19-Jul-2021, last episode of MYALGIA (muscle aches), FATIGUE (tiredness), TREMOR (chills that progressed to shaking) and HYPERHIDROSIS (awoke in the middle of the night with profuse sweating) had resolved.      DIAGNOSTIC RESULTS (normal ranges are provided in parenthesis if available): On an unknown date, SARS-CoV-2 test: inconclusive (Inconclusive) The patient was waiting for the results..         Action taken with mRNA-1273 (Moderna COVID-19 Vaccine) was not applicable.
Age: 72.0
Sex: M
Vaccine: COVID19
Symptoms: Nasopharyngitis, SARS-CoV-2 test, Tremor
Clinical narrative: muscle aches; tiredness; chills that progressed to shaking; awoke in the middle of the night with profuse sweating; flu-like symptoms; cold; shaking; chills; fatigue; muscle aches; sweating; This spontaneous case was reported by a consumer and describes the occurrence of INFLUENZA LIKE ILLNESS (flu-like symptoms), NASOPHARYNGITIS (cold), TREMOR (shaking), CHILLS (chills) and FATIGUE (fatigue) in a 72-year-old male patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch nos. 032120A and 033M20A) for COVID-19 vaccination. The occurrence of additional non-serious events is detailed below.     No medical history was provided by the reporter.  Concomitant products included MULTI VITAMIN [ASCORBIC ACID;COLECALCIFEROL;NICOTINAMIDE;PANTHENOL;PYRIDOXINE HYDROCHLORIDE;RETINOL PALMITATE;RIBOFLAVIN;THIAMINE HYDROCHLORIDE;TOCOPHERYL ACETATE], FEXOFENADINE, LEVOTHYROXINE and ATORVASTATIN for an unknown indication.   On 29-Jan-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. On 26-Feb-2021, received second dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) dosage was changed to 1 dosage form. On 27-Feb-2021, the patient experienced INFLUENZA LIKE ILLNESS (flu-like symptoms), NASOPHARYNGITIS (cold), TREMOR (shaking), CHILLS (chills), FATIGUE (fatigue), the first episode of MYALGIA (muscle aches) and HYPERHIDROSIS (sweating). On 18-Jul-2021, the patient experienced the second episode of MYALGIA (muscle aches), FATIGUE (tiredness), TREMOR (chills that progressed to shaking) and HYPERHIDROSIS (awoke in the middle of the night with profuse sweating). The patient was treated with ASPIRIN [ACETYLSALICYLIC ACID] at a dose of 2 UNK. On 28-Feb-2021, INFLUENZA LIKE ILLNESS (flu-like symptoms), NASOPHARYNGITIS (cold), TREMOR (shaking), CHILLS (chills), FATIGUE (fatigue) and HYPERHIDROSIS (sweating) had resolved. On 19-Jul-2021, last episode of MYALGIA (muscle aches), FATIGUE (tiredness), TREMOR (chills that progressed to shaking) and HYPERHIDROSIS (awoke in the middle of the night with profuse sweating) had resolved.      DIAGNOSTIC RESULTS (normal ranges are provided in parenthesis if available): On an unknown date, SARS-CoV-2 test: inconclusive (Inconclusive) The patient was waiting for the results..         Action taken with mRNA-1273 (Moderna COVID-19 Vaccine) was not applicable.
Sex: U
Vaccine: COVID19
Symptoms: Vaccination complication
Clinical narrative: Moderna vaccine spot do magnet metals such as keys; This spontaneous case was reported by a patient and describes the occurrence of VACCINATION COMPLICATION (Moderna vaccine spot do magnet metals such as keys) in a patient of an unknown age and gender who received mRNA-1273 (Moderna COVID-19 Vaccine) for COVID-19 vaccination.     No Medical History information was reported.    On an unknown date, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. On an unknown date, the patient experienced VACCINATION COMPLICATION (Moderna vaccine spot do magnet metals such as keys). At the time of the report, VACCINATION COMPLICATION (Moderna vaccine spot do magnet metals such as keys) outcome was unknown.        The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Unknown) was unknown.       No concomitant medications were reported Treatment information was not provided
Age: 26.0
Sex: F
Vaccine: COVID19
Symptoms: Malaise, Somnolence, Vaccination site reaction
Clinical narrative: The arm reaction I believe was less after the second vaccination.; sleep for the day or afternoon; I typically have when I get sick with a flu or virus; This spontaneous case was reported by a patient and describes the occurrence of VACCINATION SITE REACTION (The arm reaction I believe was less after the second vaccination.), SOMNOLENCE (sleep for the day or afternoon) and MALAISE ( I typically have when I get sick with a flu or virus) in a 26-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch nos. 001A21A and 042L20A) for COVID-19 vaccination.     Concurrent medical conditions included Allergy to molds (mild to moderate) and Pollen allergy (mild to moderate). Concomitant products included HYDROCHLOROTHIAZIDE, FAMOTIDINE, FLUVOXAMINE MALEATE, GABAPENTIN, MIRABEGRON (MYRBETRIQ), LEVOTHYROXINE SODIUM (SYNTHROID), LORATADINE (CLARITIN [LORATADINE]) and SPIRONOLACTONE for an unknown indication.   On 25-Jan-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. On 27-Feb-2021, received second dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) dosage was changed to 1 dosage form. On an unknown date, the patient experienced VACCINATION SITE REACTION (The arm reaction I believe was less after the second vaccination.), SOMNOLENCE (sleep for the day or afternoon) and MALAISE ( I typically have when I get sick with a flu or virus). At the time of the report, VACCINATION SITE REACTION (The arm reaction I believe was less after the second vaccination.), SOMNOLENCE (sleep for the day or afternoon) and MALAISE ( I typically have when I get sick with a flu or virus) outcome was unknown. Not Provided          Other concomitant medications such as pataday eye drops and patanase nasal spray. No treatment  medications were provided by the reporter.    This case was linked to MOD-2021-017719 (Patient Link).
Sex: U
Vaccine: COVID19
Symptoms: Arthralgia, Lymphadenopathy
Clinical narrative: Swollen lymph nodes; joint pain; Based on the current case data, this case has been classified as invalid. This spontaneous case was reported by a consumer and describes the occurrence of LYMPHADENOPATHY (Swollen lymph nodes) and ARTHRALGIA (joint pain) in a patient of an unknown age and gender who received mRNA-1273 (Moderna COVID-19 Vaccine) for COVID-19 vaccination.     No Medical History information was reported.    On an unknown date, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. On an unknown date, the patient experienced LYMPHADENOPATHY (Swollen lymph nodes) and ARTHRALGIA (joint pain). At the time of the report, LYMPHADENOPATHY (Swollen lymph nodes) and ARTHRALGIA (joint pain) outcome was unknown.        The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Unknown) was unknown.       No concomitant medication was reported. No treatment medication was reported.
Sex: U
Vaccine: COVID19
Symptoms: Diarrhoea
Clinical narrative: Is diarrhea part of any symptoms from having the shot; Based on the current case data, this case has been classified as invalid. This spontaneous case was reported by a consumer and describes the occurrence of DIARRHOEA (Is diarrhea part of any symptoms from having the shot) in a patient of an unknown age and gender who received mRNA-1273 (Moderna COVID-19 Vaccine) for COVID-19 vaccination.     No Medical History information was reported.    On an unknown date, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On an unknown date, the patient experienced DIARRHOEA (Is diarrhea part of any symptoms from having the shot). At the time of the report, DIARRHOEA (Is diarrhea part of any symptoms from having the shot) outcome was unknown.        The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) was unknown.       No concomitant medication information were provided. No treatment information were provided.
Sex: U
Vaccine: COVID19
Symptoms: Ageusia, Anosmia, Fatigue, SARS-CoV-2 test
Clinical narrative: Also felt extremely tired; Loss sense of smell for about 10 days; Loss sense of taste for about 10 days; This spontaneous case was reported by a consumer and describes the occurrence of ANOSMIA (Loss sense of smell for about 10 days), AGEUSIA (Loss sense of taste for about 10 days) and FATIGUE (Also felt extremely tired) in a patient of an unknown age and gender who received mRNA-1273 (Moderna COVID-19 Vaccine) for COVID-19 vaccination.     No Medical History information was reported.    On 13-Jul-2021, the patient received second dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. On an unknown date, the patient experienced ANOSMIA (Loss sense of smell for about 10 days), AGEUSIA (Loss sense of taste for about 10 days) and FATIGUE (Also felt extremely tired). At the time of the report, ANOSMIA (Loss sense of smell for about 10 days), AGEUSIA (Loss sense of taste for about 10 days) and FATIGUE (Also felt extremely tired) outcome was unknown.      DIAGNOSTIC RESULTS (normal ranges are provided in parenthesis if available): On an unknown date, SARS-CoV-2 test: negative (Negative) Negative.         No concomitant medications were reported.  No treatment information was provided.   Reporter did not allow further contact   Most recent FOLLOW-UP information incorporated above includes: On 03-Aug-2021: Dose number of vaccine, suspect start date and laboratory test were updated, along with a new event "Tiredness".
Sex: M
Vaccine: COVID19
Symptoms: Rhinorrhoea
Clinical narrative: only had sniffles the first night; This spontaneous case was reported by a consumer and describes the occurrence of RHINORRHOEA (only had sniffles the first night) in a male patient of an unknown age who received mRNA-1273 (Moderna COVID-19 Vaccine) for COVID-19 vaccination.     No Medical History information was reported.    On an unknown date, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. On an unknown date, the patient experienced RHINORRHOEA (only had sniffles the first night). At the time of the report, RHINORRHOEA (only had sniffles the first night) outcome was unknown.        The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Unknown) was unknown.
Age: 12.0
Sex: M
Vaccine: COVID19
Symptoms: Product administered to patient of inappropriate age, Vaccination site erythema, Vaccination site mass
Clinical narrative: received Moderna vaccine and he's 12 years old; a golf ball size knot that is all red at the injection site; a golf ball size knot that is all red at the injection site; This spontaneous case was reported by a patient family member or friend and describes the occurrence of PRODUCT ADMINISTERED TO PATIENT OF INAPPROPRIATE AGE (received Moderna vaccine and he's 12 years old), VACCINATION SITE MASS (a golf ball size knot that is all red at the injection site) and VACCINATION SITE ERYTHEMA (a golf ball size knot that is all red at the injection site) in a male patient of an unknown age who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 046A21A) for COVID-19 vaccination.     No Medical History information was reported.    On 17-Jul-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On an unknown date, the patient experienced PRODUCT ADMINISTERED TO PATIENT OF INAPPROPRIATE AGE (received Moderna vaccine and he's 12 years old), VACCINATION SITE MASS (a golf ball size knot that is all red at the injection site) and VACCINATION SITE ERYTHEMA (a golf ball size knot that is all red at the injection site). At the time of the report, PRODUCT ADMINISTERED TO PATIENT OF INAPPROPRIATE AGE (received Moderna vaccine and he's 12 years old) outcome was unknown.        The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) was unknown.   For mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular), the reporter did not provide any causality assessments.
Sex: U
Vaccine: COVID19
Symptoms: Faeces discoloured, Fatigue
Clinical narrative: bright yellow feces; extreme tiredness; This spontaneous case was reported by a consumer and describes the occurrence of FAECES DISCOLOURED (bright yellow feces) and FATIGUE (extreme tiredness) in a  patient of an unknown age and gender who received mRNA-1273 (Moderna COVID-19 Vaccine) for COVID-19 vaccination.     No Medical History information was reported.    On an unknown date, the patient received dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. On an unknown date, the patient experienced FAECES DISCOLOURED (bright yellow feces) and FATIGUE (extreme tiredness). At the time of the report, FAECES DISCOLOURED (bright yellow feces) and FATIGUE (extreme tiredness) outcome was unknown.        The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Unknown) was unknown.       No concomitant and treatment medications were reported.
Sex: U
Vaccine: COVID19
Symptoms: Arthralgia
Clinical narrative: Shoulder pain; This spontaneous case was reported by a consumer and describes the occurrence of ARTHRALGIA (Shoulder pain) in a patient of an unknown age and gender who received mRNA-1273 (Moderna COVID-19 Vaccine) for COVID-19 vaccination.     No Medical History information was reported.   On an unknown date, the patient received second dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. On an unknown date, received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) dosage was changed to 1 dosage form. On an unknown date, the patient experienced ARTHRALGIA (Shoulder pain). At the time of the report, ARTHRALGIA (Shoulder pain) outcome was unknown.            No relevant concomitant medications were reported. No treatment information was provided.
Age: 57.0
Sex: F
Vaccine: COVID19
Symptoms: Anxiety, Palpitations, Sleep disorder, Temperature intolerance
Clinical narrative: Heart palpitation; Heat Sensation; May have anxiety,Terribly frightening; it wakes me up out of my sleep every single night,I can't sleep peacefully anymore out of fear; This spontaneous case was reported by a consumer and describes the occurrence of PALPITATIONS (Heart palpitation), TEMPERATURE INTOLERANCE (Heat Sensation), ANXIETY (May have anxiety,Terribly frightening) and SLEEP DISORDER (it wakes me up out of my sleep every single night,I can't sleep peacefully anymore out of fear) in a 57-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch nos. 036A21A and 039K20A) for COVID-19 vaccination.     No Medical History information was reported.   On 11-Feb-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On 11-Mar-2021, received second dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) dosage was changed to 1 dosage form. On 12-Mar-2021, the patient experienced PALPITATIONS (Heart palpitation), TEMPERATURE INTOLERANCE (Heat Sensation) and ANXIETY (May have anxiety,Terribly frightening). 12-Mar-2021, the patient experienced SLEEP DISORDER (it wakes me up out of my sleep every single night,I can't sleep peacefully anymore out of fear). At the time of the report, PALPITATIONS (Heart palpitation), TEMPERATURE INTOLERANCE (Heat Sensation), ANXIETY (May have anxiety,Terribly frightening) and SLEEP DISORDER (it wakes me up out of my sleep every single night,I can't sleep peacefully anymore out of fear) outcome was unknown.            No concomitant medications were reported.  Per report, the patient experienced heat sensations and severe palpitations following dose,  which interrupted her sleep every night, but not as severe during daytime. She stated that the experience sometimes felt like an imminent heart attack. Results of diagnostic investigations ordered by the patient's cardiologist had returned as negative, as no abnormality was detected. The patient reported difficulty sleeping peacefully for fear of a recurrences at night, and she wanted to know why she had been feeling that way.  Treatment information was not provided by reporter.   Most recent FOLLOW-UP information incorporated above includes: On 02-Aug-2021: Follow-up received on 02-Aug-2021 in which Event added- (Sleep disorder)
Age: 60.0
Sex: F
Vaccine: COVID19
Symptoms: Burning sensation, Illness, Myalgia
Clinical narrative: I have pain all over; my arms are burning, my legs are burning, my skin hurts.; illness; This spontaneous case was reported by a consumer and describes the occurrence of BURNING SENSATION (my arms are burning, my legs are burning, my skin hurts.), ILLNESS (illness) and MYALGIA (I have pain all over) in a 60-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 054C21A) for COVID-19 vaccination.     Concurrent medical conditions included Degenerative arthritis peripheral joint. Concomitant products included HYDROCODONE BITARTRATE, PARACETAMOL (NORCO) for an unknown indication.   On 19-Jul-2021, the patient received second dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) dosage was changed to 1 dosage form. On an unknown date, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. On 19-Jul-2021, the patient experienced BURNING SENSATION (my arms are burning, my legs are burning, my skin hurts.) and ILLNESS (illness). On an unknown date, the patient experienced MYALGIA (I have pain all over). At the time of the report, BURNING SENSATION (my arms are burning, my legs are burning, my skin hurts.), ILLNESS (illness) and MYALGIA (I have pain all over) outcome was unknown.            Action Taken of the Drug mRNA-1273  (COVID 19 VACCINE MODERNA) of associated  with the event was Not Applicable Treatment medication information  was not provided  by the reporter Patient could not sleep. patient was drenched herself in alcohol. Is like a burning.     This case was linked to MOD-2021-261513 (Patient Link).
Age: 67.0
Sex: F
Vaccine: COVID19
Symptoms: Cough, Rhinorrhoea, Sneezing, Vaccination site induration, Vaccination site pain
Clinical narrative: Soreness at injection site; Hardness at injection site; Sneezing; Coughing; Runny nose; This spontaneous case was reported by a consumer and describes the occurrence of VACCINATION SITE PAIN (Soreness at injection site), VACCINATION SITE INDURATION (Hardness at injection site), SNEEZING (Sneezing), COUGH (Coughing) and RHINORRHOEA (Runny nose) in a 67-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) for COVID-19 vaccination.     No Medical History information was reported.    On 02-Jul-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. On 02-Jul-2021, the patient experienced VACCINATION SITE PAIN (Soreness at injection site), VACCINATION SITE INDURATION (Hardness at injection site), SNEEZING (Sneezing), COUGH (Coughing) and RHINORRHOEA (Runny nose). On 07-Jul-2021, VACCINATION SITE PAIN (Soreness at injection site) and VACCINATION SITE INDURATION (Hardness at injection site) had resolved. At the time of the report, SNEEZING (Sneezing), COUGH (Coughing) and RHINORRHOEA (Runny nose) outcome was unknown.        The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Unknown) was unknown.       No treatment medications were provided. No concomitant medications were reported.
Age: 74.0
Sex: U
Vaccine: COVID19
Symptoms: Allergy to vaccine, Epistaxis, Eye pruritus, Periorbital swelling
Clinical narrative: ALLERGY ATTACK; HEAVY NOSE BLEED/NASAL BLOOD CLOTS IN BOTH NOSTRILS; PUFFY,PURPLE COLORED BAGS UNDER BOTH EYES; ITCHY BAGS UNDER BOTH EYES; This spontaneous case was reported by a consumer and describes the occurrence of EPISTAXIS (HEAVY NOSE BLEED/NASAL BLOOD CLOTS IN BOTH NOSTRILS), PERIORBITAL SWELLING (PUFFY,PURPLE COLORED BAGS UNDER BOTH EYES), EYE PRURITUS (ITCHY BAGS UNDER BOTH EYES) and ALLERGY TO VACCINE (ALLERGY ATTACK) in a 74-year-old patient of an unknown gender who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch nos. 046A21A and 013M20a) for COVID-19 vaccination.     Concurrent medical conditions included Hay fever.   On 11-Feb-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. On 23-Mar-2021, received second dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) dosage was changed to 1 dosage form. On 20-Apr-2021, the patient experienced PERIORBITAL SWELLING (PUFFY,PURPLE COLORED BAGS UNDER BOTH EYES) and EYE PRURITUS (ITCHY BAGS UNDER BOTH EYES). On 12-May-2021 at 4:00 AM, the patient experienced EPISTAXIS (HEAVY NOSE BLEED/NASAL BLOOD CLOTS IN BOTH NOSTRILS). On an unknown date, the patient experienced ALLERGY TO VACCINE (ALLERGY ATTACK). At the time of the report, EPISTAXIS (HEAVY NOSE BLEED/NASAL BLOOD CLOTS IN BOTH NOSTRILS), PERIORBITAL SWELLING (PUFFY,PURPLE COLORED BAGS UNDER BOTH EYES), EYE PRURITUS (ITCHY BAGS UNDER BOTH EYES) and ALLERGY TO VACCINE (ALLERGY ATTACK) outcome was unknown.            Concomitant product use was not provided by the reporter.  Patient experience a heavy nosebleed and he followed the medically recommended method of pinching his nostrils and sitting with his head tilted forward.  Patient has never experienced nosebleeds prior or hand any bad allergy reactions for at least 20 years. No treatment information was provided.   This case was linked to MOD-2021-030752 (Patient Link).
Age: 72.0
Sex: F
Vaccine: COVID19
Symptoms: Alopecia
Clinical narrative: Hair falling out; This spontaneous case was reported by a consumer and describes the occurrence of ALOPECIA (Hair falling out) in a 72-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch nos. 048A21A and 011M20A) for COVID-19 vaccination.     No Medical History information was reported.   On 15-Feb-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. On 15-Mar-2021, received second dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) dosage was changed to 1 dosage form. On an unknown date, the patient experienced ALOPECIA (Hair falling out). At the time of the report, ALOPECIA (Hair falling out) outcome was unknown.            Concomitant medication was not provided Treatment information was not reported On an unspecified date, her hair started falling out. She states that she uses the same shampoo and has the same diet.   Reporter did not allow further contact
Sex: U
Vaccine: COVID19
Symptoms: Herpes zoster
Clinical narrative: Shingles; This spontaneous case was reported by a consumer and describes the occurrence of HERPES ZOSTER (Shingles) in a patient of an unknown age and gender who received mRNA-1273 (Moderna COVID-19 Vaccine) for COVID-19 vaccination.     No Medical History information was reported.    On 24-Jun-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. On an unknown date, the patient experienced HERPES ZOSTER (Shingles). The patient was treated with VALACICLOVIR HYDROCHLORIDE (VALTREX) ongoing since an unknown date for Shingles, at an unspecified dose and frequency. At the time of the report, HERPES ZOSTER (Shingles) outcome was unknown.        The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Unknown) was unknown.       Patient still feeling the nerve damage from the shingles and patient scheduled to have the second dose on Thursday   Reporter did not allow further contact
Age: 37.0
Sex: F
Vaccine: COVID19
Symptoms: Contusion, Platelet count
Clinical narrative: Lot of bruising; This case was received via an unknown source (no reference has been entered for a health authority or license partner) on 20-Jul-2021 and was forwarded to Moderna on 20-Jul-2021.    This spontaneous case was reported by a consumer and describes the occurrence of CONTUSION (Lot of bruising) in a 37-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 044A21A) for COVID-19 vaccination.     No Medical History information was reported.    On 17-Mar-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. On an unknown date, the patient experienced CONTUSION (Lot of bruising). At the time of the report, CONTUSION (Lot of bruising) outcome was unknown.      DIAGNOSTIC RESULTS (normal ranges are provided in parenthesis if available): On an unknown date, Platelet count: normal (normal) platelet count :1,50,000 and decreased (Low) platelet count :crashed to 105,000.     The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Unknown) was unknown.       Concomitant product was not provided by the reporter. Treatment information was not provided.
Sex: U
Vaccine: COVID19
Symptoms: Arthralgia
Clinical narrative: Arthric pain in joints; This spontaneous case was reported by a consumer and describes the occurrence of ARTHRALGIA (Arthric pain in joints) in a patient of an unknown age and gender who received mRNA-1273 (Moderna COVID-19 Vaccine) for COVID-19 vaccination.     No Medical History information was reported.    On an unknown date, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. On an unknown date, the patient experienced ARTHRALGIA (Arthric pain in joints). At the time of the report, ARTHRALGIA (Arthric pain in joints) outcome was unknown.        The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Unknown) was unknown.       No concomitant medications were provided. Treatment medications were unknown.
Sex: F
Vaccine: COVID19
Symptoms: Fatigue, Heart rate, Somnolence
Clinical narrative: Sleepy; exhaustion; This spontaneous case was reported by a consumer and describes the occurrence of SOMNOLENCE (Sleepy) and FATIGUE (exhaustion) in a female patient of an unknown age who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch nos. 054c21a and 009021a) for COVID-19 vaccination.     No Medical History information was reported.   On 17-Jun-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On 15-Jul-2021, received second dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) dosage was changed to 1 dosage form. On an unknown date, the patient experienced SOMNOLENCE (Sleepy) and FATIGUE (exhaustion). At the time of the report, SOMNOLENCE (Sleepy) and FATIGUE (exhaustion) outcome was unknown.      DIAGNOSTIC RESULTS (normal ranges are provided in parenthesis if available): On an unknown date, Heart rate: (High) heart rate rising fast from doing non hard activities.         No concomitant medications were reported.   No treatment information was provided.      This case was linked to MOD-2021-261475.
Sex: U
Vaccine: COVID19
Symptoms: Headache, Myalgia
Clinical narrative: Headache; Muscle soreness; This spontaneous case was reported by a consumer and describes the occurrence of HEADACHE (Headache) and MYALGIA (Muscle soreness) in a patient of an unknown age and gender who received mRNA-1273 (Moderna COVID-19 Vaccine) for COVID-19 vaccination.     No Medical History information was reported.    On an unknown date, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On an unknown date, the patient experienced HEADACHE (Headache) and MYALGIA (Muscle soreness). At the time of the report, HEADACHE (Headache) and MYALGIA (Muscle soreness) outcome was unknown.        The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) was unknown.       Concomitant drug was not reported. Treatment medication was not reported.   Reporter did not allow further contact
Sex: U
Vaccine: COVID19
Symptoms: Cough
Clinical narrative: coughing; This spontaneous case was reported by a consumer and describes the occurrence of COUGH (coughing) in a patient of an unknown age and gender who received mRNA-1273 (Moderna COVID-19 Vaccine) for COVID-19 vaccination.     No Medical History information was reported.    On an unknown date, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. On an unknown date, the patient experienced COUGH (coughing). At the time of the report, COUGH (coughing) outcome was unknown.        The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Unknown) was unknown.       No concomitant medication was mentioned. No treatment medication was mentioned.
Age: 60.0
Sex: F
Vaccine: COVID19
Symptoms: Burning sensation, Illness, Myalgia
Clinical narrative: My arms are burning, my legs are burning, my skin hurts.; Is enhancing my illness; Pain all over; This case was received via an unknown source (no reference has been entered for a health authority or license partner) on 20-Jul-2021 and was forwarded to Moderna on 20-Jul-2021.    This spontaneous case was reported by a consumer and describes the occurrence of BURNING SENSATION (My arms are burning, my legs are burning, my skin hurts.), ILLNESS (Is enhancing my illness) and MYALGIA (Pain all over) in a 60-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) for COVID-19 vaccination.     Concurrent medical conditions included Osteoarthritis. Concomitant products included HYDROCODONE BITARTRATE, PARACETAMOL (NORCO) for an unknown indication.    On an unknown date, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. On an unknown date, the patient experienced BURNING SENSATION (My arms are burning, my legs are burning, my skin hurts.), ILLNESS (Is enhancing my illness) and MYALGIA (Pain all over). At the time of the report, BURNING SENSATION (My arms are burning, my legs are burning, my skin hurts.), ILLNESS (Is enhancing my illness) and MYALGIA (Pain all over) outcome was unknown.        The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Unknown) was unknown.       Treatment information was not provided.   This case was linked to MOD-2021-261484 (Patient Link).
Sex: U
Vaccine: COVID19
Symptoms: Vaccination complication
Clinical narrative: side effects/I have side effects; This spontaneous case was reported by a consumer and describes the occurrence of VACCINATION COMPLICATION (side effects/I have side effects) in a patient of an unknown age and gender who received mRNA-1273 (Moderna COVID-19 Vaccine) for COVID-19 vaccination.     No Medical History information was reported.    On an unknown date, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. On an unknown date, the patient experienced VACCINATION COMPLICATION (side effects/I have side effects). At the time of the report, VACCINATION COMPLICATION (side effects/I have side effects) outcome was unknown.        The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Unknown) was unknown.       No relevant concomitant medications were reported. Treatment medication was not provided by the reporter.
Age: 70.0
Sex: U
Vaccine: COVID19
Symptoms: Chills, Decreased appetite, Myalgia, Pyrexia, Vaccination site erythema
Clinical narrative: Loss of appetite; 10 days later at injection site warm stayed 2-3 days got better; 10 days later at injection site red stayed for 2-3 days got better; General aches; Fever; Chills; This spontaneous case was reported by a physician and describes the occurrence of DECREASED APPETITE (Loss of appetite), VACCINATION SITE WARMTH (10 days later at injection site warm stayed 2-3 days got better), VACCINATION SITE ERYTHEMA (10 days later at injection site red stayed for 2-3 days got better), MYALGIA (General aches) and PYREXIA (Fever) in a 70-year-old patient of an unknown gender who received mRNA-1273 (Moderna COVID-19 Vaccine) for COVID-19 vaccination. The occurrence of additional non-serious events is detailed below.     No Medical History information was reported.    On an unknown date, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. On an unknown date, the patient experienced DECREASED APPETITE (Loss of appetite), VACCINATION SITE WARMTH (10 days later at injection site warm stayed 2-3 days got better), VACCINATION SITE ERYTHEMA (10 days later at injection site red stayed for 2-3 days got better), MYALGIA (General aches), PYREXIA (Fever) and CHILLS (Chills). At the time of the report, DECREASED APPETITE (Loss of appetite), VACCINATION SITE WARMTH (10 days later at injection site warm stayed 2-3 days got better), VACCINATION SITE ERYTHEMA (10 days later at injection site red stayed for 2-3 days got better), MYALGIA (General aches), PYREXIA (Fever) and CHILLS (Chills) outcome was unknown.        The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Unknown) was unknown.   For mRNA-1273 (Moderna COVID-19 Vaccine) (Unknown), the reporter did not provide any causality assessments.   No concomitant medications were reported.  No treatment details were reported.
Age: 70.0
Sex: U
Vaccine: COVID19
Symptoms: Vaccination site warmth
Clinical narrative: Loss of appetite; 10 days later at injection site warm stayed 2-3 days got better; 10 days later at injection site red stayed for 2-3 days got better; General aches; Fever; Chills; This spontaneous case was reported by a physician and describes the occurrence of DECREASED APPETITE (Loss of appetite), VACCINATION SITE WARMTH (10 days later at injection site warm stayed 2-3 days got better), VACCINATION SITE ERYTHEMA (10 days later at injection site red stayed for 2-3 days got better), MYALGIA (General aches) and PYREXIA (Fever) in a 70-year-old patient of an unknown gender who received mRNA-1273 (Moderna COVID-19 Vaccine) for COVID-19 vaccination. The occurrence of additional non-serious events is detailed below.     No Medical History information was reported.    On an unknown date, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. On an unknown date, the patient experienced DECREASED APPETITE (Loss of appetite), VACCINATION SITE WARMTH (10 days later at injection site warm stayed 2-3 days got better), VACCINATION SITE ERYTHEMA (10 days later at injection site red stayed for 2-3 days got better), MYALGIA (General aches), PYREXIA (Fever) and CHILLS (Chills). At the time of the report, DECREASED APPETITE (Loss of appetite), VACCINATION SITE WARMTH (10 days later at injection site warm stayed 2-3 days got better), VACCINATION SITE ERYTHEMA (10 days later at injection site red stayed for 2-3 days got better), MYALGIA (General aches), PYREXIA (Fever) and CHILLS (Chills) outcome was unknown.        The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Unknown) was unknown.   For mRNA-1273 (Moderna COVID-19 Vaccine) (Unknown), the reporter did not provide any causality assessments.   No concomitant medications were reported.  No treatment details were reported.
Age: 65.0
Sex: F
Vaccine: COVID19
Symptoms: Body temperature, Decreased appetite, Depression, Fatigue, Pain in extremity
Clinical narrative: Blurrred vision; Made achey as well; Depressed; No appetite; Fatigue; 100 degree fever; This spontaneous case was reported by a consumer and describes the occurrence of VISION BLURRED (Blurrred vision), PAIN IN EXTREMITY (Made achey as well), DEPRESSION (Depressed), DECREASED APPETITE (No appetite) and FATIGUE (Fatigue) in a 65-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch nos. 024M20A and 027L20A) for COVID-19 vaccination. The occurrence of additional non-serious events is detailed below.     Concurrent medical conditions included Drug allergy (statins), Allergy to antibiotic (clindamycin) and Blood pressure high since 2018. Concomitant products included LOSARTAN from 2018 to an unknown date for Blood pressure high.   On 19-Jan-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. On 02-Mar-2021, received second dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) dosage was changed to 1 dosage form. On 02-Mar-2021, the patient experienced FATIGUE (Fatigue) and PYREXIA (100 degree fever). On an unknown date, the patient experienced VISION BLURRED (Blurrred vision), PAIN IN EXTREMITY (Made achey as well), DEPRESSION (Depressed) and DECREASED APPETITE (No appetite). At the time of the report, VISION BLURRED (Blurrred vision), PAIN IN EXTREMITY (Made achey as well), DEPRESSION (Depressed) and DECREASED APPETITE (No appetite) outcome was unknown and FATIGUE (Fatigue) and PYREXIA (100 degree fever) had resolved.      DIAGNOSTIC RESULTS (normal ranges are provided in parenthesis if available): On 02-Mar-2021, Body temperature: 100 (High) 100 degree fever.         Patient experienced achey as well with the addition of a 100 degree fever for about 3 days.She had fatigue and no appetite and felt depressed as well and suffer from some depression. She also seem to had blurred vision.  Treatment information was not provided by the reporter.    This case was linked to MOD-2021-030984 (Patient Link).
Age: 65.0
Sex: F
Vaccine: COVID19
Symptoms: Pyrexia, Vision blurred
Clinical narrative: Blurrred vision; Made achey as well; Depressed; No appetite; Fatigue; 100 degree fever; This spontaneous case was reported by a consumer and describes the occurrence of VISION BLURRED (Blurrred vision), PAIN IN EXTREMITY (Made achey as well), DEPRESSION (Depressed), DECREASED APPETITE (No appetite) and FATIGUE (Fatigue) in a 65-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch nos. 024M20A and 027L20A) for COVID-19 vaccination. The occurrence of additional non-serious events is detailed below.     Concurrent medical conditions included Drug allergy (statins), Allergy to antibiotic (clindamycin) and Blood pressure high since 2018. Concomitant products included LOSARTAN from 2018 to an unknown date for Blood pressure high.   On 19-Jan-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. On 02-Mar-2021, received second dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) dosage was changed to 1 dosage form. On 02-Mar-2021, the patient experienced FATIGUE (Fatigue) and PYREXIA (100 degree fever). On an unknown date, the patient experienced VISION BLURRED (Blurrred vision), PAIN IN EXTREMITY (Made achey as well), DEPRESSION (Depressed) and DECREASED APPETITE (No appetite). At the time of the report, VISION BLURRED (Blurrred vision), PAIN IN EXTREMITY (Made achey as well), DEPRESSION (Depressed) and DECREASED APPETITE (No appetite) outcome was unknown and FATIGUE (Fatigue) and PYREXIA (100 degree fever) had resolved.      DIAGNOSTIC RESULTS (normal ranges are provided in parenthesis if available): On 02-Mar-2021, Body temperature: 100 (High) 100 degree fever.         Patient experienced achey as well with the addition of a 100 degree fever for about 3 days.She had fatigue and no appetite and felt depressed as well and suffer from some depression. She also seem to had blurred vision.  Treatment information was not provided by the reporter.    This case was linked to MOD-2021-030984 (Patient Link).